INTRODUCTION: Sampling is regarded as crucial to the validity of case-control studies. Ideally, cases and controls should be selected from the same source population, but deviations from this approach are often seen. OBJECTIVE: Our objective was to examine how exposure-disease relationships in a study on chronic obstructive pulmonary disease (COPD) were affected by the sampling sources of cases and controls. METHODS: A Norwegian case-control study on COPD including 1909 subjects used three sources of recruitment for cases (general population, hospital registry and volunteers) and two sources for controls (general population and volunteers). This resulted in six sampling combinations of cases and controls (groups A-F). We examined how the risk factors gender, age, smoking, educational level and comorbidity were associated with COPD in these six sampling groups. RESULTS: Several exposure-disease associations were dependent on variation in sampling source, thereby demonstrating the possibility of selection bias. The theoretically most ideal sampling group is likely group A, where both cases and controls are recruited from a general population. When using group A as a reference, the groups containing either voluntary controls and/or hospital-based cases deviated the most, suggesting higher susceptibility to selection bias in these groups. CONCLUSION: Recruitment from several sources made our study design vulnerable to selection bias. Our findings should bring about increased awareness to the sampling process, and encourage sampling of cases and controls from the same source population in future studies.
INTRODUCTION: Sampling is regarded as crucial to the validity of case-control studies. Ideally, cases and controls should be selected from the same source population, but deviations from this approach are often seen. OBJECTIVE: Our objective was to examine how exposure-disease relationships in a study on chronic obstructive pulmonary disease (COPD) were affected by the sampling sources of cases and controls. METHODS: A Norwegian case-control study on COPD including 1909 subjects used three sources of recruitment for cases (general population, hospital registry and volunteers) and two sources for controls (general population and volunteers). This resulted in six sampling combinations of cases and controls (groups A-F). We examined how the risk factors gender, age, smoking, educational level and comorbidity were associated with COPD in these six sampling groups. RESULTS: Several exposure-disease associations were dependent on variation in sampling source, thereby demonstrating the possibility of selection bias. The theoretically most ideal sampling group is likely group A, where both cases and controls are recruited from a general population. When using group A as a reference, the groups containing either voluntary controls and/or hospital-based cases deviated the most, suggesting higher susceptibility to selection bias in these groups. CONCLUSION: Recruitment from several sources made our study design vulnerable to selection bias. Our findings should bring about increased awareness to the sampling process, and encourage sampling of cases and controls from the same source population in future studies.
Authors: Inga-Cecilie Sørheim; Ane Johannessen; Amund Gulsvik; Per S Bakke; Edwin K Silverman; Dawn L DeMeo Journal: Thorax Date: 2010-06 Impact factor: 9.139
Authors: Robert Busch; Brian D Hobbs; Jin Zhou; Peter J Castaldi; Michael J McGeachie; Megan E Hardin; Iwona Hawrylkiewicz; Pawel Sliwinski; Jae-Joon Yim; Woo Jin Kim; Deog K Kim; Alvar Agusti; Barry J Make; James D Crapo; Peter M Calverley; Claudio F Donner; David A Lomas; Emiel F Wouters; Jørgen Vestbo; Ruth Tal-Singer; Per Bakke; Amund Gulsvik; Augusto A Litonjua; David Sparrow; Peter D Paré; Robert D Levy; Stephen I Rennard; Terri H Beaty; John Hokanson; Edwin K Silverman; Michael H Cho Journal: Am J Respir Cell Mol Biol Date: 2017-07 Impact factor: 6.914
Authors: Michael H Cho; Peter J Castaldi; Emily S Wan; Mateusz Siedlinski; Craig P Hersh; Dawn L Demeo; Blanca E Himes; Jody S Sylvia; Barbara J Klanderman; John P Ziniti; Christoph Lange; Augusto A Litonjua; David Sparrow; Elizabeth A Regan; Barry J Make; John E Hokanson; Tanda Murray; Jacqueline B Hetmanski; Sreekumar G Pillai; Xiangyang Kong; Wayne H Anderson; Ruth Tal-Singer; David A Lomas; Harvey O Coxson; Lisa D Edwards; William MacNee; Jørgen Vestbo; Julie C Yates; Alvar Agusti; Peter M A Calverley; Bartolome Celli; Courtney Crim; Stephen Rennard; Emiel Wouters; Per Bakke; Amund Gulsvik; James D Crapo; Terri H Beaty; Edwin K Silverman Journal: Hum Mol Genet Date: 2011-11-11 Impact factor: 6.150
Authors: Erica P A Rutten; Thomas B Grydeland; Sreekumar G Pillai; Scott Wagers; Asger Dirksen; Harvey O Coxson; Amund Gulsvik; Emiel F M Wouters; Per S Bakke Journal: Pulm Med Date: 2011-01-16
Authors: Einar M H Martinsen; Tomas M L Eagan; Elise O Leiten; Eli Nordeide; Per S Bakke; Sverre Lehmann; Rune Nielsen Journal: Multidiscip Respir Med Date: 2019-05-02
Authors: Lan Ai Kieu Le; Ane Johannessen; Jon Andrew Hardie; Odd Erik Johansen; Amund Gulsvik; Bjørn Egil Vikse; Per Bakke Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-07-23
Authors: Rune Grønseth; Ingvild Haaland; Harald G Wiker; Einar Marius H Martinsen; Elise O Leiten; Gunnar Husebø; Øistein Svanes; Per S Bakke; Tomas M Eagan Journal: Eur Clin Respir J Date: 2014-12-29
Authors: Elise Orvedal Leiten; Tomas Mikal Lind Eagan; Einar Marius Hjellestad Martinsen; Eli Nordeide; Gunnar Reksten Husebø; Kristel Svalland Knudsen; Sverre Lehmann; Øistein Svanes; Per Sigvald Bakke; Rune Nielsen Journal: BMJ Open Respir Res Date: 2020-03
Authors: Matthew Moll; Phuwanat Sakornsakolpat; Nick Shrine; Brian D Hobbs; Dawn L DeMeo; Catherine John; Anna L Guyatt; Michael J McGeachie; Sina A Gharib; Ma'en Obeidat; Lies Lahousse; Sara R A Wijnant; Guy Brusselle; Deborah A Meyers; Eugene R Bleecker; Xingnan Li; Ruth Tal-Singer; Ani Manichaikul; Stephen S Rich; Sungho Won; Woo Jin Kim; Ah Ra Do; George R Washko; R Graham Barr; Bruce M Psaty; Traci M Bartz; Nadia N Hansel; Kathleen Barnes; John E Hokanson; James D Crapo; David Lynch; Per Bakke; Amund Gulsvik; Ian P Hall; Louise Wain; Scott T Weiss; Edwin K Silverman; Frank Dudbridge; Martin D Tobin; Michael H Cho Journal: Lancet Respir Med Date: 2020-07 Impact factor: 102.642